208 related articles for article (PubMed ID: 27617613)
1. Lymphangitis occurring after intralesional Candida antigen injection for verruca vulgaris.
Zubritsky L; Alikhan A
Dermatol Online J; 2016 Jun; 22(6):. PubMed ID: 27617613
[TBL] [Abstract][Full Text] [Related]
2. Uveitis Following Treatment of Verruca Vulgaris with Intralesional
Crowley NJ; Hagan JC; Dyer JA; Brundige TF
Mo Med; 2017; 114(5):394-395. PubMed ID: 30228642
[TBL] [Abstract][Full Text] [Related]
3. Regression of Nevi After Candida Injection for the Treatment of Verruca Vulgaris.
Kollmann E; Cleaver D; Cleaver L; Cleaver J
Pediatr Dermatol; 2017 Mar; 34(2):199-200. PubMed ID: 27981626
[TBL] [Abstract][Full Text] [Related]
4. Treatment of recalcitrant verruca vulgaris with Candida antigen in patient with human immunodeficiency virus.
Summers P; Richards-Altmon P; Halder R
J Drugs Dermatol; 2009 Mar; 8(3):268-9. PubMed ID: 19271374
[TBL] [Abstract][Full Text] [Related]
5. Intralesional injection of mumps or Candida skin test antigens: a novel immunotherapy for warts.
Johnson SM; Roberson PK; Horn TD
Arch Dermatol; 2001 Apr; 137(4):451-5. PubMed ID: 11295925
[TBL] [Abstract][Full Text] [Related]
6. Intralesional immunotherapy of warts with mumps, Candida, and Trichophyton skin test antigens: a single-blinded, randomized, and controlled trial.
Horn TD; Johnson SM; Helm RM; Roberson PK
Arch Dermatol; 2005 May; 141(5):589-94. PubMed ID: 15897380
[TBL] [Abstract][Full Text] [Related]
7. Intralesional immunotherapy compared to cryotherapy in the treatment of warts.
Khozeimeh F; Jabbari Azad F; Mahboubi Oskouei Y; Jafari M; Tehranian S; Alizadehsani R; Layegh P
Int J Dermatol; 2017 Apr; 56(4):474-478. PubMed ID: 28108992
[TBL] [Abstract][Full Text] [Related]
8. The efficacy and safety of intralesional Candida vaccine versus topical diphencyproprobenone in immunotherapy of verruca vulgaris: A randomized comparative study.
El-Komy MHM; Shamma SG; Bedair NI
Arch Dermatol Res; 2023 Apr; 315(3):583-591. PubMed ID: 36245011
[TBL] [Abstract][Full Text] [Related]
9. Use of Candida antigen injections for the treatment of verruca vulgaris: A two-year mayo clinic experience.
Alikhan A; Griffin JR; Newman CC
J Dermatolog Treat; 2016 Aug; 27(4):355-8. PubMed ID: 26558635
[TBL] [Abstract][Full Text] [Related]
10. Combined bivalent human papillomavirus vaccine and Candida antigen versus Candida antigen alone in the treatment of recalcitrant warts.
Marei A; Nofal A; Alakad R; Abdel-Hady A
J Cosmet Dermatol; 2020 Mar; 19(3):758-762. PubMed ID: 31328869
[TBL] [Abstract][Full Text] [Related]
11. Candida albicans intralesional injection immunotherapy of warts.
Signore RJ
Cutis; 2002 Sep; 70(3):185-92. PubMed ID: 12353895
[TBL] [Abstract][Full Text] [Related]
12. Intralesional Candida Antigen Immunotherapy for the Treatment of Recalcitrant and Multiple Warts in Children.
Muñoz Garza FZ; Roé Crespo E; Torres Pradilla M; Aguilera Peirò P; Baltà Cruz S; Hernández Ruiz ME; Baselga Torres E
Pediatr Dermatol; 2015; 32(6):797-801. PubMed ID: 26584692
[TBL] [Abstract][Full Text] [Related]
13. Local and distal involution of recalcitrant warts after a single intralesional dose of measles, mumps, and rubella vaccine.
Cantor AS; Hardy CL
Dermatol Online J; 2018 Dec; 24(12):. PubMed ID: 30677806
[TBL] [Abstract][Full Text] [Related]
14. Significance of interferon gamma in the prediction of successful therapy of common warts by intralesional injection of Candida antigen.
Nofal A; Marei A; Amer A; Amen H
Int J Dermatol; 2017 Oct; 56(10):1003-1009. PubMed ID: 28791682
[TBL] [Abstract][Full Text] [Related]
15. Successful treatment of flat warts using intralesional Candida antigen.
Ritter SE; Meffert J
Arch Dermatol; 2003 Apr; 139(4):541-2. PubMed ID: 12707109
[No Abstract] [Full Text] [Related]
16. Intralesional vitamin D3 versus Candida antigen immunotherapy in the treatment of multiple recalcitrant plantar warts: A comparative case-control study.
Fathy G; Sharara MA; Khafagy AH
Dermatol Ther; 2019 Sep; 32(5):e12997. PubMed ID: 31225688
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of intralesional Candida antigen in diabetic patients with multiple warts.
Marei A; Alakad R; Wahid RM
J Cosmet Dermatol; 2021 Apr; 20(4):1248-1253. PubMed ID: 32924256
[TBL] [Abstract][Full Text] [Related]
18. Intralesional Candida antigen for common warts in people with HIV.
Wong A; Crawford RI
J Cutan Med Surg; 2013; 17(5):313-5. PubMed ID: 24067850
[TBL] [Abstract][Full Text] [Related]
19. Peripheral blood toll-like receptor 4 correlates response to candida immunotherapy of warts.
Sabry HH; Hamed AM; Salem RM; Marei AM; El Sebaey RM
Dermatol Ther; 2018 Sep; 31(5):e12691. PubMed ID: 30226014
[TBL] [Abstract][Full Text] [Related]
20. Goodbye warts, hello vitiligo: Candida antigen-induced depigmentation.
Wilmer EN; Burkhart CN; Morrell DS
Pediatr Dermatol; 2013; 30(6):e214-5. PubMed ID: 23252470
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]